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Summary 
The present knowledge on PFAS elimination in humans after the end of a dominating source of 
exposure is scarce. For PFOS and PFHxS only data from fluorochemical workers exist, while 
a few studies in general populations have reported data for PFOA after end of exposure by 
drinking water. We here report the first results of analyses of half-life for PFOS, PFHxS and 
PFOA in a Swedish general population with high exposure in drinking water following 
cessation of exposure, and compare with hitherto unpublished data on PFOS and PFOA 
elimination from the C8 study in Ohio, USA.  
Among 106 persons observed between 6 and 33 months after end of exposure to contaminated 
drinking water, the shortest half-life was observed for PFOA, mean 2.7 years. The half-life for 
PFHxS was twice as long, 5.3 years. For PFOS the mean was 3.4 years. The interindividual 
variation was substantial, with a threefold difference between the 5 and 95 percentiles. In 
addition, there were also a few extreme outliers. The estimates are well in line with 
observations in retired fluorocarbon workers, and with observations on PFOA half-live from 
the C8 study. 
Introduction 
Perfluorinated and polyfluorinated substances (PFASs) comprise a group of many different 
synthetic substances that have been produced and widely used for approximately 50 years. They 
are found in industrial applications and household products mainly due to their properties of 
withstanding heat, oil, dirt and water. PFASs are also used as surfactants in firefighting foam 
of the AFFF (Aqeuous Film Forming Foam) type (Thalheimer et al 2017).  
In the general population, the dominating sources of exposure are through diet and consumer 
products (Vestergren and Cousins, 2009; Vestergren et al, 2012). However, during the past 
decade it has become apparent that localised PFAS contamination to surface and groundwater 
occurs around military and civilian firefighting training facilities where large quantities of 
AFFF foams have been used. These substances are further disseminated by means of 
groundwater flows, and may also reach drinking water wells.  
PFASs are excreted via urine and faeces. In observational studies, based on observations in 
individuals followed over time, half-lives (T½) between 2 to 3 years were reported for PFOA, 
while longer half-lives for PFOS and PFHxS, 4 and 7 years, respectively (Table 1). Time-trend 
studies during periods of observed decay reported half-lives in similar ranges, except for PFBS 
which has a much shorter half-life, 1 month (Olsen et al, 2008). There are no human data after 
end of exposure for other PFASs. 
In animals T½ for PFASs vary markedly between species and are usually much shorter than in 
humans, with elimination half-life counted in hours or days. Reabsorption by organic anion 
transporters (OATs) in the kidneys and extensive uptake from enterohepatic circulation for 
PFOS and PFOA are believed to be more active processes in humans, slowing down the 
excretion of these substances (Lau et al; 2007). An increased renal elimination at high doses 
indicates a capacity-limited, saturable renal resorption process via high efficiency OATs 
(Loccisano et al; 2012; Andersen et al; 2006). Moreover, in a PFOA-exposed US population, 
the excretion rate was related to polymorphisms (SNPs) in tubular transporter proteins (Fletcher 
et al; 2012). The faecal elimination is little studied in humans, with the exception of some case 
reports which indicate that cholestyramine, a lipid lowering pharmaceutical, may enhance 
elimination (Genuis et al; 2010). 
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Table 1. Half-lives for PFOS,  PFHxS and PFOA in humans  
Reference  Setting Model Subjects Initial PFAS level (ng/mL; 
serum if not specified) 
Halflife (years) 
 
  
     PFOS PFHxS PFOA 
Direct observation        
Olsen et al 2007 Retired fluorochemical 
workers, followed 5 years. 
Repeated samplings with 
batch-wise analysis. 
First order 
elimination 
First and last 
sample 
22 men,  
2 women  
Age 55-75 
Median (range) 
PFOS: 626 (145-3490) 
PFHxS:  193 (16-1295) 
PFOA: 408 (72-5100) 
Median 4.6, 
range 2.4-21.7 
GM 4.8 
95% CI 4.0-5.8 
Median 7.1, 
range 2.2-27.0 
GM 7.3  
95% CI 5.8-9.2 
Median 3.4, 
range 1.5-9.1 
GM 3.5  
95% CI 3.0-4.1 
Brede el al 2010 Drinking water exposure to 
PFOA, follow –up 2 years after 
installation of charcoal filters 
First order 
elimination 
First and last 
sample 
20 children 
20 mothers 
20 men 
Median (range 
PFOS: ≈7 (2.6,33.3) 
PFHxS: ≈1.3(<0.1-13.4) 
PFOA: ≈25 (6.4-77.5)  
- - GM 3.26 
(range 1.03-
14.67) 
Bartell et al 2010 Drinking water exposure to 
PFOA, follow –up after 
installation of charcoal filter 
Repeated sampling, follow-up 
after 1 year 
First order 
elimination 
Mixed models, 
5 samples per 
person 
100 men 
100 women 
Age 53±15 
Mean, SD 
PFOA 180±209 
- - Median 2,3 
95% CI 2.1-2.4 
Gomis et al 2016 Ski waxers; followed after 
marked reduction of 
occupational exposure 
 4 men Range 250-1050 - - Median 2.4, 
range 2.0-2.8 
Time trend in 
populations; 
selected studies 
       
Spliethoff et al 2008 Dried blood spots from 
newborns; 2000-2006 
First order 
elimination 
240 samples 
per year 
Whole blood 
PFOS (0,8-2,4) 
PFHxS (1.2-2.5) 
PFOA: (0.3-1.4) 
4.1  
95% CI 3.1-7.2 
8.2 (5.4-16.2) 4.4  
95% CI 3.0-7.9 
Olsen et al 2012 Blood donors, crossectional 
sampling, USA 2000, 2006, 
and 2010 
 100 samples 
per year 
90,99 percentile 
PFOS: 70, 157  (GM≈30) 
PFHxS: 6.3,17  
PFOA:9, 19.9 (GM≈5) 
4.3  - - 
Yeung et al 2013a,b Population-based 
crossectional biomonitoring in 
two German cities 2000-2009 
 Students, 10 
samples per 
year and city 
PFOS (0,4-116) 
PFHxS (0.08-5.1) 
 
PFOA 6.0 (2.4-10)   
Halle: 4.8 
Munster:4.3 
- Halle: 8.2 
Munster 14.9 
Gomis et al 2017 Population-based cross-
sectional biomonitoring data 
from USA (NHANES, 1999-
2013) and Australia (2003-
2011)  
Population-
based 
pharmaco-
kinetic 
modelling  
NHANES: 
2000 per 
survey, 
Australia:  
24-84 pools 
per survey 
- Men: 
USA 3.8, 
Australia 4.9 
Women: 
USA 3.3 
Australia 5  
- Men: 
USA 2,4, 
Australia 2.1 
Women: 
USA 2.1 
Australia 1.8 
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Also, certain pharmaceuticals can block OATs (Inui et al 2000). Females have a slightly shorter 
PFAS half-life explained by menstrual blood losses, but there may also be other sex-specific 
elimination mechanisms (Wong et al; 2014). In summary, there is reason to expect that there 
can be a substantial inter-individual variation in elimination, which also was observed in retired 
fluorochemical workers (Olsen et al; 2007). 
Ronneby – a case study from Sweden 
In autumn 2013 a survey of groundwater quality in Blekinge county showed alarmingly high 
levels of PFASs in ground water from a glaceofluvial water reservoir, the Bredåkra delta, which 
has a military and civil airfield located in its center (Figure 1). Extended water sampling 
revealed very high levels of PFASs in outgoing drinking water from Brantafors, one of the two  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The military and civil air field and the municipal waterworks in Kallinge, Ronneby 
municipality, Sweden 
municipal waterworks in Ronneby municipality (Table 2). This waterworks provided drinking 
water to 1/3 of the households in Ronneby, a municipality with 28,000 inhabitants. The 
contaminated waterworks was closed on December 16, 2013, and clean water was promptly 
provided from Kärragården, the second waterworks in the municipality. After a few days no 
elevated levels of PFASs could be detected in the distribution network. Brantafors waterworks 
was reopened in May 2014, supplied with new coal filters and using water only from wells with 
low PFAs levels, but but the trial was ended in October 2014. During this trial the level of 
PFASs (sum of 11) were closely monitored, reaching at most 40 ng/L (i.e. well below 90 ng/L, 
the present Swedish recommended action level). 
It was soon confirmed that the fire drill site at the nearby military airport localized within the 
aquifer area had leached PFASs to the environment. Despite considerable efforts from the 
X Brantafors 
waterworks 
X training range at airfield 
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Armed Forces it has not been possible to reconstruct the detailed historical use of AFFF foams 
at the airfield, but the best estimate as to the start of the use of these foams is the mid 1980s.  
Extensive biomonitoring in the municipality population started in June 2014, starting 
approximately 6 months after end of exposure through drinking water, by open invitations and 
free of cost. During the period 2014-2016 in total 3418 persons participated. A reference group 
of 240 subjects from a nearby municipality (Karlshamn) was also examined in 2016.  
 
Table 2. PFASs levels (ng/L) in outgoing drinking water from the waterworks in Ronneby, 
Sweden on Dec 10, 2013 
 Brantafors  Kärragården 
Perfluoropentanoic acid, PFPeA 38 10 
Perfluorohexanoic acid, PFHxA 320 3.6 
Perfluoroheptanoic acid, PFHpA 32 1.4 
Perfluorooctanoic acid, PFOA 100 1.0 
Perfluorononanoic acid, PFNA <1 <1 
Perfluorodecanoic acid, PFDA <1 <1 
Perfluoroundecanoic acid, PFUnA <10 <10 
Perfluorododecanoic acid, PFDoA <10 <10 
Perfluorobutane sulfonic acid, PFBS 130 <2.6 
PErfluorohexane sulfonic acid, PFHxS 1700 4.6 
Perfluoroheptane sulfonic acid, PFHpS 60 <1 
Perfluorooctane sulfonic acid, PFOS 8000 27 
 
Half-life study 
Study group 
A panel study group (n=106) with a large age span, 4-83 years, was formed in June 2014. The 
proportion of females is 53%. The participants have donated blood regularly, initially every 
third month, then with longer intervals. Analysis of PFASs in serum is performed after each 
sampling round and the individual results are immediately reported back. 
We here report the findings from the first 7 sampling rounds (in June 2014, October 2014, 
January 2015, April 2015, September 2015, March 2016 and September 2016). The median 
number of samples per person was 6. Continued sampling twice a year is planned for several 
years to come.  
Chemical analysis 
The analyses of PFASs in serum are performed at the department of Occupational and 
Environmental medicine, Lund University, using LC-MS/MS after precipitation of proteins 
with organic solvents (Lindh et al; 2012). Isotopically labeled internal standards are used, and 
the analyses of PFOS and PFOA are part of a quality control program between analytical 
laboratories coordinated by Professor Hans Drexler, Institute and Outpatient Clinic for 
Occupational, Social and Environmental Medicine, University of Erlangen-Nuremberg, 
Germany 
We here report results from the dominating PFASs in serum: PFOS, PFHxS and PFOA 
determined as total (not isomer-specific) compounds.  
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Modelling of half-life 
A linear mixed effect model was used to assess subject-specific changes in serum PFAS 
concentrations over time and to estimate serum elimination half-lives of PFAS. The following 
mixed model was used to fit the panel data: 
lnܥ௜௝ ൌ ߙ௜ ൅ ݐ௜௝݇௜ ൅ ௜ܺߚ ൅ ߝ௜௝ ,      
where ܥ௜௝ is the serum PFAS concentrations for individual i and sampling round j, ߙ௜ is the 
subject-specific intercept, ݐ௜௝ is the time elapsed between the clean water was provided and the 
blood sample collection, ݇௜ is the subject-specific slope, ௜ܺ is a vector of fixed covariates for 
individual i, including age, gender and BMI,  ߚ is the fixed effect coefficient and ߝ௜௝ is the 
random error term. The subject-specific intercept ߙ௜, the subject-specific slope ݇௜ and the 
random error term ߝ௜௝ were modeled as random with normal distribution; others were treated as 
fixed effects.  
 
The main result for determining half-life is to estimate the mean slope (ki) and convert that to 
half-life (ln2/mean(ki). The values of ki were predicted using the best linear unbiased prediction 
(BLUP) method (Robinson 1991). To examine the variability of the half-life the predicted ki 
values were converted to half-life, after excluding a small number with negative values 
(apparently increasing serum PFAS) or extremely high half-life (with minimal ki).  
Summary half live values have been presented as either a mean half life (calculated from the 
mean elimination rate constant k) or as median half life (the median value of the individually 
modelled half life values, after excluding a small number of outliers). 
Results 
Serum levels at baseline  
The median serum level of PFHxS was 180 times higher in the investigated Ronneby population 
compared to the referents from a neighbouring municipality, 42 times higher for PFOS, and 6 
times higher for PFOA (Table 3). The distribution of PFAS levels by age is illustrated in Figure 
2.  
The participants in the panel study initially had serum levels of PFOS, PFHxS and PFOA that 
were somewhat higher than in the main Ronneby study population. The baseline levels of 
PFHxS, PFOA and PFOS in the panel study group ranged from 12.3 to 1660 ng/ml, 2.38 to 92 
ng/ml and 24.1 to 1500 ng/ml, respectively (Table 3).  
 
Table 3: Summary statistics of PFAS concentrations (ng/ml) in 106 participants in a panel study six 
months after end of exposure through contaminated drinking water (base-line investigation). 
PFAS Group 
No. of 
participants 
 
mean±sd    [min, median,max] 
Serum PFHxS Panel Study group 106  353±260 [12.3, 277, 1660] 
Main Ronneby group 3418  228±232 [0.14, 152, 1790] 
Reference group 242  1.91±5.27 [0.17, 0.84, 60.1] 
Serum PFOA Panel Study group 106  21.12±14.7 [2.38, 17.5, 92] 
Main Ronneby group 3418  13.7±12.0 [0, 10.4, 91.9] 
Reference group 242  1.77±0.81 [0.22, 1.59, 4.98] 
Serum PFOS Panel Study group 106  387±259 [24.1, 345, 1500] 
Main Ronneby group 3418  245±234 [0.58, 176, 1870] 
Reference group 242  5.68±6.19 [0.27, 4.21, 55.3] 
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Figure 2: Serum levels of PFOS, PFHxS and PFOA (ng/ml) by 
age among 3424 persons from Ronneby, participating in 
open blood samplings 2014‐2016. 
(Note: scales for y‐axis differ) 
 
The horizontal lines represent mean levels among 240 
persons from Karlshamn, a nearby municipality in Sweden 
(PFHxs 1.9 ng/ml, PFOA 1.8 ng/ml, PFOS 5.7 ng/ml). 
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Decline of serum levels during follow-up 
During the follow-up period, from June 2014 to September 2016, the average serum level for 
PFHxS declined by 25%, PFOA by 28% and PFOS by 35% (Figure 3). 
 
Figure 3: Serum concentrations of PFHxS, PFOA and PFOS in 106 participants in a panel 
study after end of exposure through contaminated drinking water 
Table 4 shows results from the linear mixed effect model and displays the exponentiated 
parameter estimates. Time after the clean water was provided was associated with a decrease 
of 0.1309 units in log serum PFHxS per year after adjusting with other covariates, indicating 
that the average effect of time since clear water was provided was to decrease PFHxS 
concentration to 88% (݁ି଴.ଵଷ଴ଽ) of its previous value each year. This elimination rate estimation 
is equivalent to mean of half-life of 5.29 years (95% CI: 4.72-6.02 years). The average decrease 
in PFOA was 77% of its previous value each year, corresponding to a mean half-life of 2.67 
years (95% CI: 2.47-2.91 years).  For PFOS, the annual decrease was to 82%, and the mean 
half-life 3.40 years (95% CI 3.12-3.74 years). Age at baseline had a strong effect on serum 
PFHxS, PFOA and PFOS concentrations with average increases of 1.54%, 1.12% and 1.44% 
per year (see also Figure 2). Gender and BMI were not significantly associated with log-
transformed PFAS concentrations. 
 
The distributions of half-lives are shown in Figure 4, after exclusion of outliers for the fitted 
estimated half-life as follows: those <0 (n=1 for PFHxS) or over 10 years (n=8 for PFHxS, n=1 
for PFOS). The median of the half-lives for PFHxS was 5.5 years (5 to 95% range 3.0-9.2 
years). For PFOS, the median of half-lives was 3.5 years (5 to 95% range 2.2 to 6.2 years). For 
PFOA, the median of half-lives for PFOA was 2.7 years (5 to 95% range 1.8 to 5.1 years). 
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Table 4: Estimated multiplicative effects on serum PFAS concentrations in 106 participants in a panel 
study after end of exposure through contaminated drinking water. 
For PFHxS   
Covariates Effect multiplier* P-level 95% CI 
Time following clean water provision (per year) 0.8773 <0.0001 0.8635-0.8914 
Female 0.9479 0.7117 0.7136-1.2594 
Age (per year) 1.0154 <0.0001 1.0081-1.0228 
BMI 0.9995 0.9775 0.9643-1.0358 
For  PFOA   
Covariates Effect multiplier* P-level 95% CI 
Time following clean water provision (per year) 0.7716 <0.0001 0.7554-0.7883 
Female 1.0238 0.8446 0.8090-1.2955 
Age (per year) 1.01119 0.0001 1.0058-1.018 
BMI 0.9908 0.5418 0.9619-1.0206 
For  PFOS   
Covariates Effect multiplier* P-level 95% CI 
Time after the clear water was provided(per year) 0.8156 <0.0001 0.8007- 0.8308 
Female 0.9981 0.9881 0.7752-1.2849 
Age (per year) 1.0144 <0.0001 1.0079-1.0209 
BMI 0.9955 0.7831 0.9644-0.9730 
*Effect multiplier are calculated from exponentiated coefficients from a log PFAS linear mixed effect 
model adjusting for all the covariates listed in the table. 
 
Discussion 
Among 106 person observed between 6 and 33 months after end of exposure to PFAS 
contaminated drinking water the shortest half-life was observed for PFOA, mean 2.67 years. 
The half-life for PFHxS was twice as long, 5.29 years. For PFOS the mean was 3.40 years.  
This pattern is similar to observations in 24 retired fluorocarbon workers, to our knowledge the 
only other study that hitherto has reported half-lives for PFOS and PFHxS after end of exposure 
that is substantially higher than the general population background (Olsen et al, 2007). The 
retired workers were older than our population, had higher serum levels of PFOA and PFOS, 
and were followed for a longer period, 5 years. 
 
Our estimate of half-life for PFOA was similar to that reported from populations living in 
PFOA-polluted areas around production plants, followed for 1-2 years after provision of clean 
drinking water (Brede et al, 2010; Bartell et al, 2010).  
 
For comparison (see data in Appendix), the estimated half-life for both PFOS and PFOA, based 
on hitherto unpublished data from a 4 year follow-up in the C8 study population, and calculated 
with the same method as for the Ronneby population, were similar. Within C8 the mean half-
life for PFOA was 2.72 years, very close to the results in Ronneby, and for PFOS the half-life 
was 3.60 years, slightly longer. It should be noted that the C8 population had serum PFOA 
levels that were substantially higher than the Ronneby population. In contrast, PFOS levels 
were much lower in the C8 population, with little direct exposure from drinking water. For 
PFOS, the population half-life has been estimated to be 4.3 years from studies in US blood  
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Figure 4: The interindividual variation of half-lives for PFAS in 106 participants in a panel 
study after end of exposure through contaminated drinking water, excluding outliers. 
 
 
donors (Olsen et al, 2012). After an abrupt end of a dominating source of exposure, as in 
Ronneby, the finding of a shorter half-life is as expected.  
 
In both the Ronneby the inter-individual variation in half-lives was substantial, with a 3-fold 
difference between the 5 and 95 percentiles, and with a few extreme outliers with extremely 
long half-lives. Large inter-individual differences were also observed in the C8 population and 
in the retired fluorocarbon workers (Olsen et al, 2007). Another next step in our study of PFAS 
elimination will be to explore the determinants for such differences.  
 
In addition to differences between individuals as to excretion capacity, recent data using paired 
human serum and urine samples for estimation of T½ have indicated marked differences 
between excretion of PFASs with different chain-length and isomers (Zhang et al, 2013). It is 
likely that linear isomers are preferentially retained (Miralles-Marco et al; 2015), but 
observational longitudinal human data on the excretion of linear versus branched chain isomers 
is absent. Thus, variation of T½ between populations and between individuals using total PFOS, 
PFOA and PFHxS determinations (as in this study) may in part reflect body burdens with 
different isomer composition.   
 
Such differences are likely to be found in humans, given the varying production methods of 
PFAS over time. Synthesis of PFAS is by electrochemical fluorination or fluorotelomerization. 
Electrochemical fluorination was used from the 1950s until the early 2000s and yielded 
branched and linear isomers. By contrast, fluorotelomerization which was later introduced 
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produces almost exclusively linear compounds (Vyas et al; 2007). The firefighting foams used 
over time have differed in composition, but there may also be varying fate of different PFAS 
structural isomers during soil and ground water transportation. Thus, it is of importance to 
include determination of both linear and branched isomers of PFOS, PFHxS, PFOA in order to 
understand differences in half-lives. 
 
Follow up of the Ronneby population provides the first time that the excretion half-life can be 
estimated in a community population with past heavy contamination with PFHxS, whose 
exposure has been stopped. The mean half-life was 5.27 years though with wide variability 
between individuals. It would be desirable to understand the causes of such variations. The 
estimated half-life for PFOA and PFOS of 2.7 and 3.4 years respectively were consistent with 
results from other studies. They also show wide variability, which needs more research to 
understand mechanisms. 
 
Limitation 
A major limitation of the present preliminary analysis as well as the C8 four year follow-up is 
that the serum samples were not analyzed in the same batch. All Ronneby samples were 
analyzed at the same laboratory with the same methods and work-up procedure, but there is still 
a need for a batched reanalysis of all samples to reduce laboratory variation. This is planned as 
a next step in our studies.  
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Appendix – the C8 study 
For comparison with Ronneby, new half-life estimates computed for both PFOA 
and PFOS are presented from the C8 study population. We here present data here 
for a larger group than previously published, with longer follow- up and data for 
PFOS for the first time. 
Study group 
In the C8 study population of the Mid-Ohio Valley, USA, some 67,000 people provided blood 
samples in a survey during 2005-6 of those who had lived for at least a year in the water supply 
district areas contaminated with PFOA from the local plant (Frisbee et al, 2009).  Within that 
cohort, a half-life study was carried out in nearly 200 people. For PFOA the mean half-life was 
2.3 years, derived from repeated measurements during the first year since public water filtration 
was introduced (Bartell et al, 2010).  Here we report findings from a larger group of over 700 
people who were invited to provide a second sample more than 4 years following the main 
survey. The first survey took place during 2005-2006, the second during 2010 (Fitz-Simon et 
al, 2013). The eligible population for recall was aged 20-60 at the time of the first survey, lived 
within approximately 40km of the blood collection clinic, had consented to be contacted and 
could be reach by telephone. People with prior cancer diagnoses and reporting active infection 
were excluded. Within this eligible population, people were randomly selected until the target 
numbers were reached. 
 
755 individuals were successfully recruited and provided blood samples for analysis, in early 
2010, with a further subgroup of 411 supplying a subsequent second sample. The first survey 
was between Aug 2005 and July 2006, the second between Mar 2010 and Sept 2010, the third 
survey was during October 2010. The mean time between the first and second survey was 4.4 
years, and from first to third survey 4.8 years. 
 
PFASs were assayed in serum samples by accredited labs and serum concentration of PFOA 
and PFOS were above the detection limit in all participants (Frisbee et al, 2009; Fitz-Simon et 
al, 2013). Serum concentrations were thus available for two time points in 755 individuals and 
three time points for 411. Some data were missing (eg for BMI) and in the final models 743 
participants contributed at least 2 measurements for the modelling of excretion. 
 
Most (724) of this study population were exposed through their domestic water supplies from 
one of four of the water supply districts with PFOA contamination. These water supplies 
received treatment technology to remove PFOA at various dates as follows: March 2006 for 
Belpre, May 2006 for Tuppers Plain, June 2007 for Lubeck and November 2007 for Little 
Hocking (Fitz-Simon et al, 2013). Residents in the Little Hocking water district had received 
large supplies of bottled water prior to filtration and were advised not to consume tap water, 
and as a consequence their date of stopping intake was uncertain. Therefore, for the analysis of 
PFOA excretion and half-life, the study population was restricted to individuals resident in the 
other three districts (Belpre, Lubeck and Tuppers Plain water districts), and the date of stopping 
intake was taken to be the date of first blood sample or the date of filtration being introduced, 
whichever was later. The serum level measured at first round was applied at that date. 445 
individuals were followed up in those three districts for PFOA excretion. On average, the time 
for this population from drinking water filtration being supplied to the last blood sample taken 
was 3.9 years. 
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PFOS contamination was not related to a local source but national restrictions of use of PFOS 
in products had dramatically reduced primary exposure to PFOS (Gomis et al, 2017). Thus the 
population’s excretion greatly exceeded its intake and the half-life can be estimated by follow- 
up from the first sample for all 745 individuals.  However the PFOS intake during follow up, 
while much reduced would not have been zero, given the persistence and with some presumed 
ongoing exposure to PFOS, the estimated half would overestimated, but this is considered to 
be only a small degree. PFHxS and PFNA were also measured in the repeat samples, but neither 
had been subject to regulatory restrictions as PFOS, and serum levels hardly changed over the 
4 years and thus these data are uninformative for estimating half-lives for these compounds. 
 
Chemical analysis 
At baseline, concentrations were determined using protein precipitation followed by reversed-
phase high-performance liquid chromatography/tandem mass spectrometry (Frisbee et al, 
2009). At follow-up, the approach followed an online solid phase extraction coupled with 
reversed-phase high-performance liquid chromatography separation and detection by isotope-
dilution tandem mass spectrometry (Kato et al, 2011a). The two techniques are known to pro- 
duce equivalent results for the analysis of serum PFAAs (Keller et al, 2010). Furthermore, both 
laboratories participated in an interlaboratory study that reported a reasonable agreement, 
particularly for PFOS and PFOA (Van Leeuwen et al, 2006).  
 
Modelling of half-lives 
A linear mixed effect model was used to assess subject-specific changes in serum PFAS 
concentrations over time and to estimate serum elimination half-lives of PFAS. The following 
mixed model was used to fit the panel data: 
 
lnܥ௜௝ ൌ ߙ௜ ൅ ݐ௜௝݇௜ ൅ ௜ܺߚ ൅ ߝ௜௝ ,      
 
where ܥ௜௝ is the serum PFAS concentrations for individual i and sampling round j, ߙ௜ is the 
subject-specific intercept, ݐ௜௝ is the time elapsed between the clean water was provided and the 
blood sample collection, ݇௜ is the subject-specific slope, ௜ܺ is a vector of fixed covariates for 
individual i, specifically age, gender and BMI,  ߚ is the fixed effect coefficient and ߝ௜௝ is the 
random error term. The subject-specific intercept	ߙ௜, the subject-specific slope ݇௜ and the 
random error term ߝ௜௝ were modeled as random with normal distribution; others were treated as 
fixed effects. 
 
The main result for determining half-life is to estimate the mean slope (ki) and convert that to 
half-life (ln2/mean(ki). The values of ki were predicted using the best linear unbiased prediction 
(BLUP) method (Robinson, 1991). To examine the variability of the half-life the predicted ki 
values were converted to half-life, after excluding a small number with negative values 
(apparently increasing serum PFAS) or extremely high half-life (with minimal ki) 
 
Results 
Serum levels of PFOA and PFOS at the first and second survey are reported in Table 1. PFOA 
dominates, while PFOS levels are in range that can be observed in a US general population 
(Kato et al, 2011b).  
 
Table 2 shows results from the linear mixed effect model and displays the exponentiated 
parameter estimates. The average effect of time since clean water was provided was to decrease 
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PFOA concentration to 82% of its previous value each year. This elimination rate estimation is 
equivalent to a mean of half-life of 2.72 years (95% CI 2.52 – 2.90). The average effects of time 
to decrease PFOS was 82% of its previous value each year, corresponding to a mean half-life 
of 3.60 years (95% CI 3.45 – 3.76). Females had significantly lower PFAS levels. Little effect 
of BMI fitted as a continuous variable. 
 
 
Table 1: Descriptive statistics of PFOA and PFOS concentration at base-line and follow-up in individuals 
from the C8 study. PFOS all water districts, PFOA 3 water districts (see methods). 
 
    
No. of 
individuals Mean Sd min median max 
PFOA Survey 1 455 75.5 154.6 1.00 49.1 2495.3 
Survey 2 455 41.5 138.2 0.25 18.5 2140.0 
PFOS Survey 1 755 23.2 14.4 0.25 20.3 93.3 
Survey 2 755 10.9 7.49 0.10 9.20 61.0 
 
 
 
 
 
Table 2: Estimated multiplicative effects on serum PFAS concentrations in individuals from the C8 study 
 
For PFOS in C8 population n=743   
Covariates Effect multiplier* P-level 95% CI 
Time during follow up 2005-10 (per year) 0.8248 <0.0001 0.8179-0.8318 
Female 0.7162 <0.0001 0.6480-0.7916 
Age (per year) 1.0064 0.0048 1.0020-1.0109 
BMI 0.9934 0.0813 0.9859-1.0008 
    
For  PFOA in C8 population of 3 water districts n=437   
Covariates Effect multiplier* P-level 95% CI 
Time since the clean water was provided (per year) 0.7750 <0.0001 0.7594-0.7873 
Female 0.9199 0.3915 0.7594-1.1143 
Age (per year) 1.0196 <0.0001 1.0109-1.0284 
BMI 0.9880 0.096 0.9741-1.0022 
 
 
After excluding some outliers for the fitted estimated half-life (<0 (for PFOA n=9 and for PFOS 
n=6) or over 10 years (for PFOA n= 15 and for PFOS n=10)), the distribution of half-life is 
illustrated in Figure 1, with median values of  2.76 years for PFOA (5 to 95% range 1.44-5.82 
years)., and 3.72 years for PFOS (5 to 95% range 2.39-5.98 years).  
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Figure 1. The distribution of half-lives for PFOA in 437 individuals and PFOS in 727 individuals from the 
C8 study. 
 
Discussion 
For PFOA, modelling of serum measurements of 437 individuals with an average of 3.9 years 
follow-up from provision of clean water in 3 water districts to the last measurement, resulted 
in an estimated average half-life of 2.72 years (95% CI 2.52 – 2.90). This is a little longer than 
the half-life of 2.3 years in the first year already reported (Bartell et al, 2010), however the 
populations are not entirely comparable. The population in the Bartell study was more weighted 
to individuals with higher initial PFOA levels and they note that the Little Hocking 
subpopulation (which was excluded from our analysis due to uncertainty in the date of stopping 
PFOA intake) were most exposed and showed a shorter half-life, suggesting results more 
consistent with the current findings for the remaining population. The main limitations of the 
current study was that we could not take into account the role of reported bottled water usage, 
and that our model assumes that first measured serum sample was representative of the serum 
at the date of water filtration that may have been several months later. A further limitation is 
that analyses were done by different laboratories at different times. 
 
For PFOS, modelling of serum measurements of 743 individuals with an average of 4.8 years 
follow-up from first serum sample to the last measurement, resulted in an estimated average 
half-life of 3.60 years (95% CI 3.45 – 3.76). To be a true indicator of half-life during this 
observation period, then intake must have stopped completely. This is unlikely to be the case, 
thus the fall would be slower and the true half-life would be overestimated.  However the rate 
of fall in PFOS intake is estimated to be steep (Gomis et al, 2017) and thus this bias is expected 
to be quite small. 
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